University of Alabama at Birmingham - 1720 University Blvd is a clinical research site located in Birmingham, Alabama, United States 35233.
Crixeo Clinical Trials Trust Score: 92/100 (GOOD). This profile has not yet been claimed by the site owner.
University of Alabama at Birmingham - 1720 University Blvd has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
Sponsors: argenx.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Alabama · View every site in Birmingham
Trust Score: 92/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Alabama at Birmingham - 1720 University Blvd has a Crixeo Trust Score of 92/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Alabama at Birmingham - 1720 University Blvd has 1 clinical trials on record, with 1 currently active. Their work covers Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
University of Alabama at Birmingham - 1720 University Blvd has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.